4SC AG

Immunic wraps up €17.5M Series A, buys immunology programs from 4SC

Immunic has raised €17.5 million from LSP and LifeCare Partners in a Series A round and bought cytokine inhibitor and Crohn’s disease programs from 4SC.

Nick Paul Taylor Sep 28, 2016 3:42am

4SC shelves U.S. Nexavar combo trial after Asian PhII misses primary endpoint

Jun 1, 2016 4:37am